• Mergers & Acquisitions


  • Healthcare


  • Assoc. for Corporate Growth, New York
  • Advisory Board Member, Last Mile Research


James Metcalf is a Managing Director at B. Riley Securities and a member of the firm's Healthcare & Life Sciences practice.

Prior to joining B. Riley, Mr. Metcalf served as a Managing Director and leader in Huron's investment banking affiliate. He brings over 17 years of experience advising publicly traded, financial sponsor-backed, and privately held organizations across all facets of the healthcare industry including acute care, behavioral health, post-acute care, ancillary and pharmaceutical services, payors, healthcare IT, distribution companies, and physician practice management. Earlier in his career, he worked in EY's and Morgan Keegan's US healthcare investment banking practices and has held positions in corporate finance, banking, and global equities at Bank of America Securities and J.P. Morgan.

Mr. Metcalf holds a Master of Business Administration from the Leonard N. Stern School of Business at New York University and a Bachelor of Science in Business & Accounting from Franklin and Marshall College in Lancaster, Pennsylvania. He is a FINRA registered representative with Series 7 and Series 63 licenses.

B. Riley Securities provides a full suite of investment banking, corporate finance, advisory, research, and sales and trading services. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary small-cap equity research. B. Riley Securities formerly operated as B. Riley FBR following the merger of B. Riley & Co. and FBR & Co.